Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.50
-0.01 (-0.06%)
May 29, 2026, 4:00 PM EDT - Market closed
Select Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,521 | 5,453 | 5,187 | 4,826 | 4,609 | 6,205 | |
Revenue Growth (YoY) | 45.91% | 5.12% | 7.48% | 4.70% | -25.71% | 12.16% |
Cost of Revenue | 4,897 | 4,824 | 4,553 | 4,254 | 4,208 | 5,285 |
Gross Profit | 624.2 | 629.3 | 633.64 | 571.61 | 401.49 | 919.37 |
Selling, General & Admin | 160.79 | 154.41 | 225.87 | 170.19 | 153.04 | 146.98 |
Depreciation & Amortization Expenses | 143.16 | 140.3 | 142.87 | 135.69 | 132.16 | 202.65 |
Other Operating Expenses | -1.59 | -1.59 | -3.41 | -1.52 | -28.45 | -144.03 |
Total Operating Expenses | 302.36 | 293.13 | 365.33 | 304.37 | 256.74 | 205.59 |
Operating Income | 321.84 | 336.17 | 268.32 | 267.24 | 144.75 | 713.77 |
Interest Income | 54.02 | 54.52 | 63.9 | 41.34 | 27.98 | 49.78 |
Interest Expense | -117.21 | -117.94 | -157.45 | -168.86 | -137.47 | -135.99 |
Other Non-Operating Income (Expense) | - | - | - | - | - | 2.16 |
Total Non-Operating Income (Expense) | -63.19 | -63.42 | -93.55 | -127.52 | -109.49 | -84.05 |
Pretax Income | 258.66 | 272.75 | 174.77 | 139.72 | 35.27 | 629.72 |
Provision for Income Taxes | 55.08 | 58.22 | 44.78 | 29.25 | 16.72 | 129.77 |
Net Income | 20.17 | 146.22 | 214.04 | 243.49 | 158.99 | 402.23 |
Minority Interest in Earnings | 70.04 | 68.31 | 82.67 | 56.24 | 39.03 | 97.72 |
Earnings From Discontinued Operations | - | - | 315.28 | 373.72 | 179.48 | - |
Net Income to Common | 20.17 | 146.22 | 214.04 | 243.49 | 158.99 | 402.23 |
Net Income Growth | - | -31.69% | -12.10% | 53.14% | -60.47% | 55.30% |
Shares Outstanding (Basic) | 121 | 123 | 125 | 123 | 125 | 135 |
Shares Outstanding (Diluted) | 121 | 123 | 125 | 123 | 125 | 135 |
Shares Change (YoY) | -3.55% | -1.58% | 1.23% | -1.22% | -7.51% | 3.83% |
EPS (Basic) | 1.06 | 1.16 | 1.66 | 1.91 | 1.23 | 2.98 |
EPS (Diluted) | 1.06 | 1.16 | 1.66 | 1.91 | 1.23 | 2.98 |
EPS Growth | 16.48% | -30.12% | -13.09% | 55.28% | -58.73% | 54.40% |
Shares Outstanding | 124.02 | 124.02 | 128.96 | 128.37 | 127.17 | 133.89 |
Free Cash Flow | 152 | 117.24 | 295.69 | 352.86 | 94.45 | 220.69 |
Free Cash Flow Growth | 29.65% | -60.35% | -16.20% | 273.58% | -57.20% | -74.97% |
Free Cash Flow Per Share | 1.25 | 0.96 | 2.37 | 2.87 | 0.76 | 1.64 |
Dividends Per Share | 0.250 | 0.250 | 0.438 | 0.500 | 0.500 | 0.500 |
Dividend Growth | - | -42.86% | -12.50% | - | - | - |
Gross Margin | 11.31% | 11.54% | 12.22% | 11.84% | 8.71% | 14.82% |
Operating Margin | 5.83% | 6.17% | 5.17% | 5.54% | 3.14% | 11.50% |
Profit Margin | 3.69% | 3.93% | 5.72% | 6.21% | 4.30% | 8.06% |
FCF Margin | 2.75% | 2.15% | 5.70% | 7.31% | 2.05% | 3.56% |
EBITDA | 465 | 476.47 | 472.21 | 475.98 | 350.58 | 916.42 |
EBITDA Margin | 8.42% | 8.74% | 9.10% | 9.86% | 7.61% | 14.77% |
EBIT | 321.84 | 336.17 | 268.32 | 267.24 | 144.75 | 713.77 |
EBIT Margin | 5.83% | 6.17% | 5.17% | 5.54% | 3.14% | 11.50% |
Effective Tax Rate | 21.30% | 21.34% | 25.62% | 20.94% | 47.42% | 20.61% |